Paratek Pharmaceuticals’ NUZYRA® Receives FDA Fast Track Designation for the…
-- Phase 2b Study in MAB Pulmonary Infections Ongoing and Enrolling as Planned -- Nonclinical Studies in MAC Initiating BOSTON, June 21, 2022 (GLOBE NEWSWIRE) -- Paratek…
Browsing Tag
abscessus
Paratek Pharmaceuticals Announces Enrollment of First Patient in Phase 2b Study…
BOSTON, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the first patient has been enrolled in the company’s Phase 2b study evaluating…